Jefferies Group LLC Bei Gene, Ltd. Put Options Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 15, 2020	BUY	$121.84 - $173.19 $170,576 - $242,466	1,400 Added 77.78%	3,200 $394,000
Q4 2019 Feb 13, 2020	SELL	$115.78 - $208.34 $7.04 Million - $12.7 Million	-60,800 Reduced 97.12%	1,800 $298,000
Q3 2019 Nov 13, 2019	BUY	$120.61 - $148.29 $6.27 Million - $7.71 Million	52,000 Added 490.57%	62,600 $7.67 Million
Q4 2018 Feb 14, 2019	BUY	$107.01 - $175.15 $1.13 Million - $1.86 Million	10,600 New	10,600 $1.49 Million

250

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.8B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.